Evaluation and Management of Worsening Midsternal Chest Pain
This patient requires urgent evaluation for chronic coronary syndrome (CCS) with immediate ECG, risk stratification, and objective testing to exclude obstructive coronary artery disease, as the 10-year history with recent worsening and exertional pattern strongly suggests cardiac ischemia that demands systematic workup before considering alternative diagnoses.
Initial Assessment Priority
The clinical presentation—midsternal chest pain worsening over time, occurring both at rest (twice monthly) and with increased activity at work—fits the profile of possible cardiac ischemia and must be evaluated as such until proven otherwise 1, 2. The absence of food relationship, fever, or chills makes gastrointestinal and infectious etiologies less likely but does not exclude cardiac disease.
Key Historical Features to Document
Focus your history on these specific cardiac predictors:
- Pain characteristics: Pressure, squeezing, heaviness, or tightness (not stabbing or sharp) increases likelihood of ischemia 2
- Radiation pattern: Pain radiating to shoulders, arms, jaw, or neck significantly increases probability (likelihood ratios 2.3-4.7) 3
- Exertional relationship: The fact that pain occurs "mostly at work with more activity" is highly suggestive of effort-induced ischemia 1, 2
- Rest symptoms: Twice-monthly rest pain raises concern for unstable angina or microvascular dysfunction 1
- Relieving factors: Relief with rest or nitroglycerin would further support ischemic origin 2
Critical pitfall: Do not dismiss this as "atypical" chest pain—this terminology is discouraged because it falsely implies benign etiology 2. Instead, classify as "cardiac," "possibly cardiac," or "noncardiac" only after objective testing.
Diagnostic Algorithm
Step 1: Immediate Evaluation (Same Day)
- 12-lead ECG at rest and ideally during symptoms 2
- Physical examination focusing on cardiac auscultation for murmurs, S3/S4 gallops
- Cardiovascular risk factor assessment (age, diabetes, hypertension, smoking, family history)
Step 2: Clinical Likelihood Assessment
Calculate pretest probability of obstructive CAD using the patient's age, sex, cardiovascular risk factors, and pain characteristics 1:
- Very low likelihood (≤5%): Consider deferring further testing
- Low-moderate likelihood (>5-50%): Proceed with coronary CT angiography (CCTA) as first-line test 1
- Moderate-high likelihood (>15-85%): Proceed with functional imaging (stress echo, nuclear perfusion, or stress cardiac MRI) 1
- Very high likelihood (>85%): Consider direct invasive coronary angiography 1
Given this patient's 10-year history with progressive worsening and clear exertional component, they likely fall into moderate-high likelihood category.
Step 3: Objective Testing Strategy
For moderate clinical likelihood: Order CCTA to assess for obstructive CAD 1. This provides anatomic assessment and can rule out significant stenosis.
If CCTA shows obstructive CAD or if clinical likelihood is high: Proceed to functional testing (stress imaging) to assess for inducible ischemia and quantify myocardium at risk 1, 4.
If severe ischemia or high-risk features: Proceed directly to invasive angiography 1.
Step 4: If Obstructive CAD is Ruled Out
Do not stop here—this is a critical pitfall 1. If symptoms persist after excluding obstructive CAD, you must evaluate for:
- Coronary microvascular dysfunction (CMD): Requires invasive coronary function testing with acetylcholine or adenosine to assess microvascular reserve 1
- Coronary vasospasm: Provocative testing during invasive angiography 1
- INOCA/ANOCA syndromes (ischemia/angina with non-obstructive coronary arteries) 1
The 2024 ESC guidelines emphasize that many patients with "typical" anginal symptoms have microvascular disease rather than obstructive CAD, and this requires specific functional testing 1.
Management Framework
If Obstructive CAD Confirmed:
- Lifestyle modification and risk factor control (statins, antiplatelet therapy, blood pressure/diabetes management) 1
- Antianginal medications: Beta-blockers first-line, add calcium channel blockers or long-acting nitrates as needed 1
- Revascularization (PCI or CABG) if: high-risk anatomy, severe ischemia on testing, or symptoms refractory to medical therapy 1
If Microvascular Dysfunction or Vasospasm:
- Medical management with antianginal combinations
- Consider calcium channel blockers for vasospasm
- Acknowledge that revascularization is not indicated 1
Critical Clinical Pearls
Do not be falsely reassured by:
- Normal resting ECG (present in majority of stable angina patients)
- Absence of "classic" radiation patterns (only 10-25% have truly typical angina) 1
- Long symptom duration (chronic symptoms can still represent progressive CAD)
Red flags requiring urgent evaluation:
- Crescendo pattern (increasing frequency/severity)—present in this case
- Rest pain episodes—present in this case
- These suggest possible transition from stable to unstable coronary syndrome
The worsening pattern over 10 years with increasing frequency demands action now—this is not stable disease and requires systematic cardiac evaluation before attributing symptoms to non-cardiac causes 1, 2.